The gene PRDM2 showed a mutation pattern of mutual exclusivity with CDKN2A and is of particular interest since PRDM2 is a binding partner of RB1, a well‐established melanoma driver [62, 63]. The gene discussed is CDKN2A; the disease is melanoma.